Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M. Buzon MJ, et al. J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25. J Virol. 2014. PMID: 24965451 Free PMC article.
Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo.
Andreu S, von Kobbe C, Delgado P, Ripa I, Buzón MJ, Genescà M, Gironès N, Del Moral-Salmoral J, Ramírez GA, Zúñiga S, Enjuanes L, López-Guerrero JA, Bello-Morales R. Andreu S, et al. Among authors: buzon mj. Front Microbiol. 2023 May 3;14:1185504. doi: 10.3389/fmicb.2023.1185504. eCollection 2023. Front Microbiol. 2023. PMID: 37206325 Free PMC article.
Deep molecular characterization of HIV-1 dynamics under suppressive HAART.
Buzón MJ, Codoñer FM, Frost SD, Pou C, Puertas MC, Massanella M, Dalmau J, Llibre JM, Stevenson M, Blanco J, Clotet B, Paredes R, Martinez-Picado J. Buzón MJ, et al. PLoS Pathog. 2011 Oct;7(10):e1002314. doi: 10.1371/journal.ppat.1002314. Epub 2011 Oct 27. PLoS Pathog. 2011. PMID: 22046128 Free PMC article.
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
Llibre JM, Buzón MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, Palmer S, Stevenson M, Blanco J, Martinez-Picado J, Clotet B. Llibre JM, et al. Among authors: buzon mj. Antivir Ther. 2012;17(2):355-64. doi: 10.3851/IMP1917. Epub 2011 Sep 28. Antivir Ther. 2012. PMID: 22290239 Clinical Trial.
HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activation.
Rodriguez-Plata MT, Urrutia A, Cardinaud S, Buzón MJ, Izquierdo-Useros N, Prado JG, Puertas MC, Erkizia I, Coulon PG, Cedeño S, Clotet B, Moris A, Martinez-Picado J. Rodriguez-Plata MT, et al. Among authors: buzon mj. J Immunol. 2012 Jun 15;188(12):6036-45. doi: 10.4049/jimmunol.1200267. Epub 2012 May 11. J Immunol. 2012. PMID: 22581857
Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification.
Massanella M, Esteve A, Buzón MJ, Llibre JM, Puertas MC, Gatell JM, Domingo P, Stevenson M, Clotet B, Martinez-Picado J, Blanco J; IntegRal Collaborative Group. Massanella M, et al. Among authors: buzon mj. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):152-60. doi: 10.1097/QAI.0b013e318289439a. J Acquir Immune Defic Syndr. 2013. PMID: 23392458
Modelling HIV-1 2-LTR dynamics following raltegravir intensification.
Luo R, Cardozo EF, Piovoso MJ, Wu H, Buzon MJ, Martinez-Picado J, Zurakowski R. Luo R, et al. Among authors: buzon mj. J R Soc Interface. 2013 May 8;10(84):20130186. doi: 10.1098/rsif.2013.0186. Print 2013 Jul 6. J R Soc Interface. 2013. PMID: 23658114 Free PMC article. Clinical Trial.
66 results